Dual-pharmacology muscarinic antagonist and β₂ agonist molecules for the treatment of chronic obstructive pulmonary disease.
about
Positioning new pharmacotherapies for COPDCombination bronchodilator therapy in the management of chronic obstructive pulmonary diseaseInvestigational beta-2 adrenergic agonists for the treatment of chronic obstructive pulmonary disease.Nonhuman targets in allergic lung conditions.New dual-acting bronchodilator treatments for COPD, muscarinic antagonists and β2 agonists in combination or combined into a single molecule.Bifunctional Drugs for the Treatment of Respiratory Diseases.Safety of inhaled long-acting anti-muscarinic agents in COPD.Open-Label, Randomized, 6-Way Crossover, Single-Dose Study to Determine the Pharmacokinetics of Batefenterol (GSK961081) and Fluticasone Furoate When Administered Alone or in Combination.Inhalation by design.Pharmacokinetics and pharmacodynamics of GSK961081, a novel inhaled muscarinic antagonist β2 -agonist, and fluticasone propionate administered alone, concurrently and as a combination blend formulation in healthy volunteers.
P2860
Q26798659-702E8067-0EAD-4E10-AAA1-672A5A0D537CQ27012625-4C4C1D8F-B195-44ED-BEEF-A11A0A77A529Q30397854-D6F99C05-E97B-42BF-B76B-09EA101D5DDCQ38077545-58C4611C-3D17-43E8-A9CE-DD7AF68A3A84Q38130337-C5E99217-E691-4084-A37A-E00B61A80F31Q38992596-34A7053C-B9A6-4D8F-A63D-A7418355F10FQ39232425-5E5C927A-BFB5-4B71-877D-53A6D9A70A4CQ39773324-3A3CC028-B964-432D-BF1F-C2C3214152FAQ51676366-3B543733-80EF-4315-A414-4A9570E3BEB2Q51713892-3BB20DF6-C93D-40FA-A664-D42371AC44FB
P2860
Dual-pharmacology muscarinic antagonist and β₂ agonist molecules for the treatment of chronic obstructive pulmonary disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Dual-pharmacology muscarinic a ...... obstructive pulmonary disease.
@en
Dual-pharmacology muscarinic a ...... obstructive pulmonary disease.
@nl
type
label
Dual-pharmacology muscarinic a ...... obstructive pulmonary disease.
@en
Dual-pharmacology muscarinic a ...... obstructive pulmonary disease.
@nl
prefLabel
Dual-pharmacology muscarinic a ...... obstructive pulmonary disease.
@en
Dual-pharmacology muscarinic a ...... obstructive pulmonary disease.
@nl
P2860
P356
P1476
Dual-pharmacology muscarinic a ...... obstructive pulmonary disease.
@en
P2093
Adam D Hughes
P2860
P304
P356
10.4155/FMC.11.106
P50
P577
2011-10-01T00:00:00Z